GENEVA, March 16 -- HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL CO., LTD. (No. 866, Moganshan Road, GongShu DistrictHangzhou, Zhejiang 310011), 杭州中美华东制药有限公司 (中国浙江省杭州市拱墅区莫干山路866号) filed a patent application (PCT/CN2025/118973) for "PHARMACEUTICAL COMPOSITION OF GLP-1R AGONIST AND EMPAGLIFLOZIN AND USE" on Sep 04, 2025. With publication no. WO/2026/052001, the details related to the patent application was published on Mar 12, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed ...